What We Do
Head for the Cure Support
Who We Are

    BTTC NEWS

    BTTC Clinical Trial Results Get Presented at ASCO

    Dr. Raizer was asked to present the results of the BTTC 08-01 clinical trial at the recent meeting of the American Society of Clinical Oncology. The trial was a phase II study of bevacizumab and erlotinib after radiation therapy and temozolomide in patients with newly diagnosed glioblastoma (GBM) without MGMT promoter methylation.

     
    For more of this story, click here.
     
     
    BTTC on Houston Radio
     
    Dr. Mark Gilbert and Terri Armstrong, Ph.D. were interviewed on Houston P.A. in October, 2013. They spoke about the BTTC, Head for the Cure, the advances in brain tumor research as well as what led them to their career paths.
     
    For more of this story, click here.

    OUR INSTITUTIONS

    Each of the participating BTTC institutions are committed to discovering new and effective therapies for the treatment of patients with brain tumors with compassion and understanding. BTTC is a network of medical centers with the expertise and strong desire to participate in state-of-the-art clinical trials investigating new treatments for malignant brain tumors.

     

    For the participating BTTC institutions, click here.

     

     

    OUR DOCTORS

    The doctors who are participating in the BTTC are compassionate experts in their respective fields and are dedicated to finding new and effective therapies for the treatment of patients with brain tumors.
     
    For the participating BTTC doctors, click here.

    FOLLOW US ON FACEBOOK

    The BTTC updates Facebook daily with helpful information and the latest news and research. Find other patients and caregivers that you can connect with.

     

    Follow The Brain Tumor Trials Collaborative.